What is important & what is notOnc is within a whisker of announcing a phase 3 entry/ deal with Pancreatic cancer.
They were invited & sponsored by PanCan.
That is important.
Assuming they go the partnership/ licensing deal, that would elevate not only the SP. well into the $15 range, it would also increase the corporate value in general.
That is important.
Yes, they have been using the ATM, to fund operations.
I can't prove how many shares.....don't care.... that is not important.
The only time total share count matters is it/ when a company buyout takes place.
Right now. If you go on oncolytics biotech web site they list shares as of last quarter.
presently assuming 70million shares which is what they have posted as of May 8th.
that equates to $14.28/ps/ billion$$.
Assuming the .buyout is $3-$5 billion, as a few have mentioned, the SP, becomes $42- $70 range
Adding an addional 5 million shares. Would move those numbers down a whopping .80/ share on a billion buyout.
I could go in with mutiple scenarios.Take away.
In the last year;Onc has not doubled their share count.
however with now 2 phase two ready opportunities, has easy doubled the business value of the company.
The share count only matters on a buy- out.
To me a red- herring distraction.....not important.
The upcoming " deal" with panc phase 3 is important.
They said final information within 90 days.
That is very important
They also post cash flow runway well into next year....That is important.
Gives them negotiating strength.